INTRODUCTION
Anaemia is a common haematological disorder in dogs and is an important cause of morbidity and mortality. Non-regenerative anaemia (NRA) in dogs is defined by a reticulocyte count of less than 60×10 3 / µ L (Stockham & Scott 2008 ) and can be due to inflammatory or neoplastic diseases, iron deficiency (chronic blood loss) or bone marrow insufficiency (myelophthisis, myelodysplasia, aplasia induced by toxic agents or metabolic/endocrine diseases). Acute haemorrhagic and haemolytic anaemia can also display non-regenerative features initially (Thrall 2012 ) . Regenerative anaemia (RA) is secondary to haemorrhagic states (such as vascular injury or bleeding disorders) or haemolysis with or without involvement of the immune system (vector-borne, inflammatory or neoplastic diseases, oxidative stress, toxics, hypophosphataemia, hereditary causes or idiopathic ; Thrall 2012 ) . Finding the cause of anaemia allows for appropriate treatment and improves both prognosis and survival. The pathogenesis and aetiology of anaemia in dogs have been detailed only through retrospective studies but the retrospective design did not allow for accurate identification of a causative mechanism in all cases (Kerl & Hohenhaus 1993 , Callan et al . 1996 , Useh et al . 2003 , Chervier et al . 2012 , Liu & Su 2015 . Only two studies indicated the prevalence of anaemia of infectious causes with 35/456 (7·68%) and 287/2037 (14·1%) cases, respectively (Chervier et al . 2012 , Liu & Su 2015 . The latter indicated that Babesia gibsoni was the most important vector-borne haemopathogen (VBH) causing severe anaemia but, for the majority of cases, the exact pathogenesis of anaemia was not further detailed (Liu & Su 2015 ) . Additionally, VBH were not systematically sought through comprehensive testing, so their frequency might have potentially been underestimated. This observation is more critical while facing haemolysis, as VBH can cause haemolytic anaemia and are emerging in Europe (Chomel 2011 ) . In France, the prevalence of canine babesiosis can be up to 33% depending on the time period and area considered (Bourdoiseau 2006 ) and is particularly common in Southwestern areas (Halos et al . 2013 ) . Additionally, leishmaniasis occurs mainly in Southern France (Chamaillé et al . 2010 ) whereas ehrlichial diseases have been sporadically documented (Beaufils et al . 2002 ) . There are no published prospective studies using systematic comprehensive screening for VBH to assess their frequency, clinical and biological impact in anaemic dogs. Therefore, we prospectively described the clinical and biological impact of VBH in anaemic dogs admitted, over a one-year period, at the Veterinary Teaching Hospital of VetAgro Sup, Lyon, France. Additional aims were to evaluate the association between VBH and haemolysis and to detail aetiology of anaemia.
SUBJECTS Study design
Client-owned dogs were prospectively enrolled from the internal medicine, oncology and intensive care unit (ICU) services of the Veterinary Teaching Hospital of VetAgro Sup, Lyon (France), between April 1, 2014 and March 31, 2015 . This one-year period was chosen to evaluate the frequency of VBH so as to take into account the seasonal activity of the vectors. Anaemic dogs were included when haematocrit (Ht) ≤37% and haemoglobin (Hb) ≤12 g/dL (Van Hove et al . 2000 ) . Dogs were excluded from the study if they were given doxycycline or imidocarb dipropionate at any time before presentation.
Sampling method
Surplus blood collected via a 21 gauge needle from the jugular vein was placed into both ethylenediamine tetra-acetic acid and dried tubes that were stored at 5±1°C before VBH screening. All dogs were initially sampled for diagnostic purpose and additional testing was performed on excess discarded blood. Thus, a specific approval from our institutional ethical committee was not required.
Screening for VBH SNAP 4Dx Plus test (IDEXX) was performed on whole blood or sera to detect antibodies directed against Anaplasma species, Ehrlichia species, Borrelia burgdorferi and antigens of Dirofilaria immitis . SNAP Leishmania test (IDEXX) was used to detect antibodies directed against Leishmania infantum . The accuracy of these tests has been recently studied. Indeed, sensitivity and specificity of the first test were >89% for detection of antibodies of Anaplasma phagocytophilum / platys , B . burgdorferi , Ehrlichia canis and Ehrlichiosis ewingii , antigens of Dirofilaria species (Stillman et al . 2014 ) whereas sensitivity and specificity of the later were 56 and 100%, respectively (Rodríguez- Cortés et al . 2013 ) .
Deoxyribonucleic acid (DNA) extraction and polymerase chain reaction (PCR) analysis were performed at the Laboratory of Parasitology of VetAgro Sup (Lyon, France). PCR amplification of mitosin gene specific for dogs confirmed the presence of canine DNA and the absence of PCR inhibition (Criado-Fornelio et al . 2003 ) . Then, two multiplex PCR amplifications were performed to detect DNA of E . canis , A . platys , A . phagocytophilum , Babesia and Theileria species, Hepatozoon species, Rickettsia species and Mycoplasma species using specific primers (Tables S1 and S2 , Supporting Information). The amplification reactions were carried out in a thermocycler (Biometra) in a total of 25 µ L containing 1·25 µ L of 2 µ M of each primer, 12·5 µ L of 2x Type-it Multiplex PCR Master mix (Qiagen Multiplex PCR Kit), 1 µ L DNA and 9 µ L of RNase free water and the following conditions were applied: 95°C 5 minutes, 35 cycles at 95°C 30 seconds, 61°C 90 seconds, 72°C 30 seconds and 60°C 30 minutes. A negative control (reaction mix without DNA) and a positive control (mix of pathogens DNA and dog DNA) were systematically included in parallel. For all Babesia and Theileria species positive samples, species were characterised using a PCR-Restriction Fragment Length Polymorphism method using TaqI and HinfI enzymes adapted on Babesia and Theileria species products of amplification (Carret et al . 1999 , Solano-Gallego et al . 2008 . For all positive samples for Mycoplasma species, digestion with restriction endonucleases was conducted to confirm the nature of the amplified product. Digestion with HindIII produces two fragments of 484 and 96 bp in Candidatus Mycoplasma haematoparvum and no cut in Mycoplasma haemocanis , whereas digestion with XbaI produces three fragments of 86, 201 and 291 bp in Candidatus Mycoplasma haematoparvum and two fragments 267 and 288 bp in M . haemocanis .
Blood smears were stained using the May Grünwald Giemsa method (MGG) and specifically observed by light microscopy for detection of any parasites.
Medical records
The one-year study period allowed estimation of the annual incidence of anaemia in dogs in our institution that was defined as the ratio of total number of anaemic dogs to the total dog population presented to the hospital during the study period. Signalment, complete history about previous treatments (including chemotherapy), vaccination or potential exposure to toxic drugs, relevant clinical and haematological findings were all recorded. When available, biochemistry profile, lactate concentration, saline agglutination test (SAT), direct antiglobulin test (DAT; ImmunO; MP Biomedicals) and coagulation profile were considered. All analyses were performed with the same automated haematological (Sysmex XT-2000iV analyser; Sysmex) and biochemical (Konelab 30i; Thermo Scientific) analysers at the Laboratory of Haematology and Biochemistry of VetAgro Sup, Lyon, France. Results of urinalysis (analysed within one hour of collection) included dipstick chemistry (positive/negative result for bilirubin) and microscopic evaluation of urine sediment to differentiate haematuria from haemoglobinuria, haematuria being defined at ≥5 red blood cell (RBC)/high power field (hpf ) (Reine & Langston 2005 ) . Further investigations (diagnostic imaging, cytology, histology, blood gasometry, antinuclear antibody testing) were not reported within the manuscript but were considered to achieve final diagnosis. To reduce the risk of misclassification, NRA and RA were separated based on manual count of reticulocyte evaluated at least three days after admission upon repeated microscopic examination of blood smear (Brilliant Cresyl Blue stain, cut-off value: 60,000/ µ L, Stockham & Scott 2008 ) . Cases were further classified according to causative mechanism and presumptive final diagnosis, by a small animal internal medicine resident (TB), a board-certified internist (JLC), oncologist (FP), clinical pathologist (BR), one specialist in emergency and critical care (IGT) and a clinician with exclusive expertise in haematology/immunology and infectious diseases (LC).
RAs were divided into acute haemolysis, evidenced by haemoglobinuria or hyperbilirubinemia according to the definition of Balch & Mackin ( 2007 ) , and haemorrhagic states. The former were further divided into immune-mediated haemolytic anaemia (IMHA) and anaemia associated with inflammatory conditions (including infectious and non-infectious diseases), microangiopathic diseases or toxic/oxidative damage. Hereditary haemolytic anaemia and anaemia caused by hypophosphatemia were not diagnosed in any of the cases. IMHA was defined according to the criteria of Engelbrecht et al . ( 2002 ) by all or part of positive DAT, positive SAT and spherocytosis (defined as >45 spherocytes/hpf ) on blood smear. These were either idiopathic, when no underlying disease was found, or secondary to inflammatory conditions, infectious (VBH), neoplastic diseases or toxics. Haemorrhagic states were separated into vascular injury and coagulation disorders. For NRA, cytology or histology of bone marrow was performed when deemed necessary, at the discretion of the attending clinician. When available, the results of these examinations were considered to determine the cause of NRA, which were divided into central anaemia associated with extramedullary suppression of erythropoiesis; inflammatory states including pure systemic inflammatory response syndrome (SIRS), myelosuppressive drugs, neoplastic, metabolic or infectious diseases, and intramedullary disease; malignancy, iron deficiency, inflammatory/infectious disease and primary or secondary central immune-mediated anaemia (defined by positive DAT or specific features of erythroid lineage on bone marrow cytology). SIRS was defined, according to the definition provided by Brady & Otto ( 2001 ) , as a combination of at least two of the following findings; tachycardia (heart rate >120 bpm), tachypnoea (respiratory rate >20 bpm), hyperthermia (>39·0°C) or hypothermia (<37·0°C), leucocytosis [>18,000 white blood cell (WBC)/ µ L] or leucopenia (<5000 WBC/ µ L). Increased C-reactive protein (CRP) and globulin levels or serum electrophoresis patterns (homogeneous focal spike-like peak of any focal region or any gammopathy) were also considered suggestive of inflammatory disease for both RA and NRA.
Definition of vector-borne haemopathogenassociated anaemia
The dogs with vector-borne haemopathogen-associated anaemia (VBHAA) were defined as anaemic dogs diagnosed with at least one of the following: babesiosis, granulocytic/thrombocytic anaplasmosis, monocytic ehrlichiosis, leishmaniasis, dirofilariasis, hepatozoonosis or rickettsial diseases and PCR positivity for Mycoplasma species. For all anaemic dogs with positive PCR for Mycoplasma species, we did not consider a relationship or causality but we only reported an association of anaemia and PCR positivity instead. We assumed that the haemopathogen could be either a fortuitous discovery, or a weak contributor to the anaemic state. The VBH was never considered primarily responsible for the anaemia and another diagnosis was further assigned in all cases. In this setting, anaemic dogs with positive PCR for Mycoplasma species were not considered as having haemotropic mycoplasmosis and were not treated accordingly. Borrelia burdorferi is not considered as a haemopathogen and anaemia is not a specific feature of canine borreliosis according to the American College of Veterinary Internal Medicine Consensus Statement by Littman et al . ( 2006 ) . Thus, anaemic dogs with only positive serology for Borrelia burgdorferi on SNAP 4Dx Plus test were not included within the VBHAA group.
In all, VBHAA cases corresponded to anaemic dogs with at least one positive PCR for E . canis , A . platys , A . phagocytophilum , H . canis , Babesia / Theileria , Hepatozoon species, Rickettsia species and Mycoplasma species and/or positive SNAP Leishmania (according to the LeishVet guidelines provided by SolanoGallego et al . 2011 ) , and/or positive SNAP 4Dx Plus test for Anaplasma species, Ehrlichia species, or Dirofilaria species without other apparent reasons for the anaemia. All results were reported in a spreadsheet on a word processing software (Microsoft Excel 2010; Microsoft Corporation) for statistical analysis. Data analysis Analysis was performed using statistical software (R studio, version 7·6; R Foundation for Statistical Computing). All the clinicopathological findings were included. Numerical values were reported as mean (± sd) and median (minimum to maximum range). For continuous variables, distribution and normality were assessed using graphical methods, and the respective frequencies were calculated using an exact binomial test with 95% confidence interval (CI) for all dogs then for VBHAA and non-VBHAA cases. Univariate analysis was carried out to identify explanatory variables associated with VBHAA. For categorical data, Fisher ' s exact test was used. For continuous variables, a Mann-WhitneyWilcoxon test and one-way analysis of variance (ANOVA) were carried out. Categorical variables that were significant at the 20% level were taken forward in a multiple logistic regression analysis with manual backwards elimination. To overcome the small number of VBHAA cases, the second-order Akaike Information Criteria for small samples was estimated. Models were tested until the lowest value was reached. Adjusted odds ratio (OR) and 95% CI were subsequently estimated for the variables retained in the final model. All tests were two-sided.
Vector-borne pathogens in canine anaemia

RESULTS
Characteristics of the study population During the study period, 7038 dogs were presented to the three services (internal medicine, oncology and ICU). Of these, 155 were anaemic, corresponding to an estimated total annual incidence of anaemia in dogs of 2·20% (CI, 1·87 to 2·57). Twentyone dogs (10 females and 11 males) were excluded because they were previously given doxycycline or imidocarb diproprionate; twelve dogs had NRA and the remaining nine had RA. Consequently, 134 dogs were finally included. Among them 56, 41 and 37 cases were recruited in oncology, internal medicine clinics and ICU, respectively. The most represented breeds included Bernese mountain dog (BMD: 10), German shepherd (9), golden retriever (9), Labrador retriever (7), Yorkshire terrier (6) and mixed breed (6). Only BMD were significantly overrepresented among anaemic dogs when compared with their occurrence in the general population of dogs presented to the three clinics (8·06 versus 0·85%, OR: 9·37, P<0·001). Figure 1 represents the repartition of anaemic dogs with emphasis on VBH. Among the cases included, 51 (38·1%) and 83 (61·9%) displayed RA and NRA, respectively. The RA category included 28 haemorrhagic cases 28/51 (54·9%) and 23 acute haemolytic cases (45·1%). Causes of haemorrhagic anaemia included blood loss with vascular injury (17/28, 60·7%) and coagulation disorders (11/28, 39·3%). Among the 11 dogs with coagulation disorders, there were three with babesiosis. Two of these dogs had severe thrombocytopenia (<35,000 platelet/ µ L) according to early definitions provided by Groves et al . ( 1975 ) and Williams & Maggio-Price ( 1984 ) , which was deemed responsible for primary haemostatic disorders leading to disseminated intravascular coagulation. Buccal mucosal bleeding time was not evaluated in any dog. The third dog had moderate thrombocytopenia (90,000/ µ L), prolonged prothrombin and activated partial thromboplastin times without other aetiology found following comprehensive investigation. Canine babesiosis was considered the most probable diagnosis, as it can also cause secondary haemostatic disorders (Rafaj et al . 2009 , Goddard et al . 2013 . The haemolysis was immune-mediated (IMHA) in 11/23 cases (46·8%). IMHAs were primary in 9/11 cases and secondary in the remaining 2/11 cases (one babesiosis and one haemophagocytic syndrome). Haemolysis was associated with inflammatory conditions in 8/23 cases (34·8%), including infectious (7/8, among them six babesiosis) and idiopathic inflammatory diseases (1/8). Microangiopathic anaemia due to neoplasia and toxic/oxidative damage were both reported in 2/23 cases (8·70%). In all, VBH (babesiosis in all cases) were observed in 7/23 haemolytic cases (30·4%).
Causes of anaemia
NRA included presumptive extramedullary suppression of erythropoiesis in 70/83 cases (84·3%) and intramedullary diseases 13/83 (15·7%). Bone marrow examination was performed in 47/83 NRA cases (56·6%), including 34/70 and 13/13 extramedullary and intramedullary diseases. The former were associated with SIRS (34/70, 48·6%), neoplastic diseases (27/70, 38·6%) and myelosuppressive drugs, metabolic diseases and VBH (each 3/70, 4·29%). Among the cases with SIRS, babesiosis was diagnosed in one dog. The referring veterinarian identified anaemia seven days before presentation to our institution. This dog displayed clinical signs of SIRS (with increased CRP), no current sign of haemolysis, haemorrhage or regeneration (serial reticulocyte counts below 20,000/ µ L), and died within 48 hours of hospitalisation. After the completion of all testing, there was no other reason than the SIRS due to babesiosis to explain the prolonged (>9 days) non-regenerative anaemic state. Intramedullary diseases included malignancies (lymphoid leukaemia) and iron deficiency in 5/13 cases each (38·5%), immune-mediated central anaemia in 2/13 cases (15·4%), and leishmaniasis in the remaining dog (1/13, 7·69%)
Results of VBH screening Twenty-two (16·4%) dogs had at least one positive PCR, 10 dogs (7·46%) had one positive SNAP 4Dx plus test, and another one (0·75%) had positive SNAP Leishmania test. Among the 22 dogs with at least one positive PCR, 9/22, 8/22, 2/22 and 1/22 were tested positive for B . canis , Mycoplasma species, A . platys , and E . canis , respectively. The remaining 2/22 dogs were concurrently positive for B . canis and Mycoplasma species: both were diagnosed with babesiosis. The 10 dogs with positive SNAP 4Dx plus test included 7/10, 2/10 and 1/10 dogs with positive serology for B . burgdorferi , Anaplasma species, and Ehrlichia species, respectively. The dogs with positive serology for Anaplasma species (2/3), and Ehrlichia species (1/3) were those with positive PCR for A . platys and E . canis .
The sera of 4/7 dogs with positive serology for B . burgdorferi , were submitted to an IDEXX reference laboratory (Saint-Denis, France) for subsequent quantitative C 6 ELISA assay as described by Levy et al . ( 2008 ) . All four dogs had low antibody levels (<30 U/mL), and thus, were considered as false positive. Among the three remaining dogs with positive serology for B . burgdorferi , one was assigned a diagnosis of acute haemoabdomen and went to surgery, the second had NRA secondary to a non-proteinuric IRIS stage 3/4 chronic kidney disease whereas the third had lymphoid leukaemia.
In all, VBHAA cases comprised the 22 PCR-positive dogs and the one diagnosed with leishmaniasis (23/134, 17·2%). Therefore, non-VBHAA cases were 111/134 (82·8%). VBH represented the second most common cause of haemolysis with 7/23 cases (30·4%). Among VBHAA cases, 11/23 dogs were diagnosed with babesiosis (47·8%), two with thrombocytic anaplasmosis (8·70%), and one of each with monocytic ehrlichiosis and leishmaniasis (4·35%). Additionally, 10/23 dogs (43·5%) had positive PCR for Mycoplasma species. All (8/8) dogs monoinfected with Mycoplasma species were enrolled in oncology clinic. Enzymatic restriction indicated that these dogs were all infected with the same subtype: M . haemocanis whereas the two other dogs diagnosed with babesiosis were co-infected with Candidatus Mycoplasma haematoparvum. Five of these dogs had lymphoma, two had histiocytic sarcoma and one had erythrophagocytic syndrome.
Risk analysis
Upon univariate analysis the following clinicopathological findings were further included in the multivariable regression model: being male, cardiopulmonary signs, haemolysis, positive SAT, positive DAT, high serum lactates, need for transfusion, bilirubinuria, haematuria, hyperthermia. Tables 1 and 2 In the final regression model, males were overrepresented (OR: 2·82, P=0·03) and haemolysis was more frequent among dogs with VBHAA (OR: 3·31, P=0·01).
DISCUSSION
Among 134 anaemic dogs included, the frequency of VBHAA cases was 17·2%. Male dogs were overrepresented among VBHAA cases. Dogs with VBHAA did not display specific clinical signs but had less severe anaemia and more RA, lower WBC and neutrophil counts, and showed haemolysis more frequently than non-VBHAA cases. PCR-positivity for Mycoplasma species was frequent and all anaemic dogs tested positive for M . haemocanis had neoplastic condition.
Our referral population differs from that of first opinion practices and so the frequencies of VBH and aetiology of anaemia recorded are only relevant to the population of dogs presented at our institution and may not reflect overall tendencies of the global population of anaemic dogs. Information about geographical origin or seasonal variation was not studied. Indeed, the information may well differ in another geographical location or in a primary care clinic.
We reported a high frequency of VBHAA (17·2%), as compared with those reported in the two studies available for comparison (Chervier et al . 2012 , Liu & Su 2015 . The reasons for this higher prevalence might be related to the study protocol, in which we prospectively evaluated each single dog for VBH by using exhaustive screening. We considered it likely that the true prevalence of VBHAA may have been underestimated, as 21 dogs were excluded from the study because they were previously given either doxycycline or imidocarb dipropionate by the referring veterinarian. It remains impossible to know the cause of anaemia for these dogs. However, considering medical data, we strongly believe that no more than a quarter of them had VBHAA. Thus their exclusion might not have impacted the results. One must consider geographic influence on the frequency of VBHAA, especially in endemic areas for VBH. Indeed, two Nigerian studies reported overall frequencies of VBHAA of 42% (48/114) and "parasitic anaemia" of 94·2% (2016/2139), respectively (Useh et al . 2003 , Kamani et al . 2011 . Although, the current findings are specific to our institution, they support the need for systematic screening for VBH while treating anaemic dogs.
PCR positivity for Mycoplasma species was frequent and occurred in almost half of VBHAA cases (10/23). Interestingly, three dogs with positive PCR for Mycoplasma species, presented with lameness and articular pain. Haemotropic mycoplasmosis is not reported as a clinically relevant infection in dogs and the majority of cases are asymptomatic (Kemming et al . 2004 , Chalker 2005 , Roura et al . 2010 ). However, immunosuppression, concurrent infections, neoplasia or splenectomy have been reported to promote the onset of clinical signs (Messick 2004 , Roura et al . 2010 , Sykes et al . 2004 , 2005 . In our study, it is difficult to assess the clinical impact of Mycoplasma species because two dogs were co-infected with Babesia canis and the remaining eight cases enrolled in the oncology clinic had concurrent neoplastic disease. The frequency of PCR positivity for M . haemocanis in our population (10/134, 7·46%) is less than that of 71/460 (15%) dogs in Southern France in another report (Kenny et al . 2004 ). In our study, enzyme restriction allowed for differentiation between M . haemocanis and Candidatus Mycoplasma haematoparvum. Interestingly, all anaemic dogs with neoplasia were infected with M . haemocanis whereas Candidatus Mycoplasma haematoparvum was found in the two dogs with babesiosis. 
P<0.05 indicated significant difference between the 2 sub-populations. RBC red blood cell count, MCV mean corpuscular volume, MCH mean corpuscular haemoglobin, MCHC mean corpuscular haemoglobin concentration, WBC white blood cell count This finding differs from previous reports in which haemotropic mycoplasmosis due to Candidatus Mycoplasma haematoparvum seems more frequent in dogs with cancer (Sykes et al . 2004 (Sykes et al . , 2005 . Regardless of concurrent disease, the frequency and distribution of haemotropic mycoplasmosis in the population differed from the study in Southern France, which found 44/460 dogs (9·6%) infected with Candidatus Mycoplasma haematoparvum whereas only 15/460 (3·3%) were infected with M . haemocanis ; the 12 remainders were co-infected with both haemopathogens (Kenny et al . 2004 ) . The role of the VBH as an incidental finding, a weak contributor or an important pathogen merits further attention. The finding of a specific subtype ( M . haemocanis ) in anaemic dogs with neoplasia should prompt oncologists to consider this haemopathogen. VBHAA represented the second most common cause of haemolytic anaemia in our study. In the subset of dogs evaluated, involvement of the immune system, as evidenced by positive DAT, was more frequent in VBHAA cases (6/16 versus 4/39). Interestingly, both babesiosis (Köster et al . 2015 ) and infection with Mycoplasma species (Messick 2004 ) can induce RBC injury through immune-mediated mechanisms (IMHA). Only 55 dogs underwent DAT at all and only one third of VBHAA cases were tested, making it difficult to draw clear conclusions. It would have been interesting to perform DAT in all dogs with positive PCR for VBH, especially those with cancer-related anaemia and concurrent positive PCR for Mycoplasma species, to precisely define the underlying mechanism for anaemia in those cases.
BMD were significantly overrepresented, probably because a large subset (4/10) were diagnosed with cancer-related anaemia (two lymphoma, one malignant histiocytosis and one haemophagocytic syndrome). BMD are primarily affected by histiocytic malignancies (Moore 1984 , Moore & Rosin 1986 , Fulmer & Mauldin 2007 , Abadie et al . 2009 , Brønden et al . 2010 , Dobson 2013 . They also might be overrepresented among dogs with lymphoma (Brønden et al . 2010 .
The present study is the first to report the frequency of haemolysis, which was documented in 23/134 cases (17·2%, CI: 11·2 to 24·6). A retrospective study by Brønden et al . ( 2010 ) reported that dogs with IMHA represented 0·35% of the hospital ' s population, which is in accordance with our results (23/7038 cases, which corresponds to an average annual incidence of 0·33%). We have assigned each individual anaemic case a presumptive mechanism and diagnosis with circumspection, leading to the creation of 15 subgroups. Accordingly, our data are difficult to compare with that obtained in other studies where many cases are assigned to "other" or "unknown causes" category because of insufficient information. For instance, the study of Chervier et al . ( 2012 ) reported an overall frequency for anaemia of inflammatory disease of 28·5% (130/456) while we further detailed one idiopathic polyarthritis and causes of 34 SIRS for RA and NRA, respectively, reaching 35/134 cases (26·1%). The same report detailed 12·9% (59/456) cases of immune-mediated anaemia when we reported 11 IMHA and two immune-mediated central anaemia in RA and NRA, respectively (9·70%, 27/134).
In the final regression model, male dogs were overrepresented among VBHAA cases. Males might have exploratory behaviour that increases tick exposure and thus infection with VBH. A similar sex predilection has also been highlighted for other infectious diseases like canine leptospirosis (Ward et al . 2002 ) . The reason why males were overrepresented in the VBHAA group warrants further investigations. VBHAA cases were less severe, as compared with non-VBHAA cases: they had higher Hb, Ht and RBC count. This is in agreement with the results of the study by Chervier et al . ( 2012 ) , which reported that in almost all infectious disease-related anaemic cases, the anaemia was only mild to moderate (32/35, 91·4%). In our study, we supposed that dogs with VBHAA were presented earlier during the course of their disease (especially in an emergency setting) because of an acute onset of severe clinical signs so that the anaemia associated may not have worsened over a long period unlike for the dogs with non-VBHAA. These findings should be interpreted with caution until they are confirmed in larger cohorts.
Mean reticulocyte count was significantly higher in dogs with VBHAA and we identified a trend towards an increase in erythrocyte indices in this subgroup. The number of circulating reticulocytes increases in response to an elevated erythropoietic activity of the bone marrow. A greater response is documented with haemolytic anaemia than with haemorrhagic state probably because, like in humans, iron and proteins of the damaged RBC stay available for erythropoiesis (Cowgill et al . 2003 ) . Moreover, reticulocytes are larger than mature erythrocytes and contain less Hb content. So, our findings, regarding reticulocyte and erythrocyte indices, may be explained by the higher rate of RA due to significantly higher frequency of haemolysis among VBHAA cases. It would have been interesting to evaluate reticulocyte haemoglobin content, reticulocyte volume and immature reticulocyte fraction in addition to the absolute reticulocyte count to clearly define the implication of reticulocyte indices on erythrocytic indices.
White blood cell counts were lower in dogs with VBHAA, mainly because of decreased neutrophil counts. Vector-borne haemopaghogens (mainly babesiosis) are well-documented and established causes of inflammation and leucocytosis (Kucer et al . 2008 , Weltan et al . 2008 ). However, early inflammation can contribute to short-term neutropenia by migration of neutrophils from blood vessels to inflamed tissue, but this occurs only within the first hours of inflammation (Jackson 2010 ) . Other causes of decreased WBC and neutrophil counts include decreased production by bone marrow or increased destruction from immune-mediated, inflammatory, infectious or neoplastic disease. Conversely, a thorough examination of non-VBHAA reveals that nine dogs had WBC >50,000/ µ L. They probably contributed to the apparently higher WBC count; four had lymphoid leukaemia, one peritonitis, one idiopathic polyarhtritis, one pyometra, one vasculitis and one unspecified SIRS. This difference regarding WBC and neutrophil counts between VNHAA and non-VBHAA cases needs further investigations.
The uncontrolled design of this study is a major limitation. However, we carried out the screening for VBH only in nature of the statistics and small number of dogs in the VBHAA group that would have contributed to a type II error. In this setting, any conclusions must be tentative and should be corroborated through further prospective study. Moreover, some anaemic dogs might not have been included, as a haemogram is not performed for every dog presented at our institution. Furthermore, even though one author (TB) was responsible for collection of samples and interpretation of data, there was still reliance on the attending clinicians for accurate recording in our medical database. Despite our effort, some cases may have been miscategorised.
To conclude, among 134 anaemic dogs presented, over the one-year period, to our institution, the rate of VBHAA cases was high (17·2%). Male dogs were overrepresented among VBHAA cases, which did not display specific clinical signs, had less severe and more RA, lower WBC and neutrophil counts. Haemolysis was more frequent in dogs with VBHAA than in dogs with non-VBHAA. Mycoplasma species represented almost half of VBHAA cases. PCR-positivity for the pathogen was frequent in anaemic dogs with cancer, which were all infected with the same subtype: M . haemocanis . The clinical relevance of this discovery, and broadly of haemotropic mycoplasmosis in dogs with cancer warrants further attention. While these findings remain specific to a tertiary-care hospital in our geographic area, they suggest considering VBH while facing anaemic dogs.
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